A Family case of von Hippel-Lindau syndrome
Problems of Endocrinology · 2025
DOI: 10.14341/probl13510 ↗Kurz gefasst
Fallbericht in der Zeitschrift Problems of Endocrinology, 2025. Verfasst von R A Atanesyan und 5 weiteren Autor:innen. Beteiligte Einrichtung: Stavropol State Medical University; Regional endocrinological dispensary. Hauptthemen laut MEDLINE: von Hippel-Lindau Disease, Von Hippel-Lindau Tumor Suppressor Protein, Pheochromocytoma, Adrenal Gland Neoplasms. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Von Hippel-Lindau syndrome (FHL) is a rare autosomal dominant disease that leads to the formation of multiple organ tumor syndrome. The pathology is primarily caused by the inactivation of the VHL gene, which is located on chromosome 3 (3p25/26) and encodes ubiquitin ligase, which destroys hypoxia-induced factor-1α (HIF-1α). The genetic defect leads to the accumulation of HIF-1a protein, activating key carcinogenic pathways, and activated cytokines cause abnormal proliferation of tumor cells and oncogenesis. To date, more than 500 mutations have been registered in VHL. FHL syndrome is characterized by various tumors, including hemangioblastomas of the retina and central nervous system, pheochromocytomas, clear cell renal cell carcinoma, cystic adenoma and others. In the presented clinical description, pheochromocytoma was initially diagnosed in the patient’s mother, and 2 months later in the eldest son. Subsequently, the results of a molecular genetic study made it possible to verify the diagnosis, since in the gene in exon 3 of VHL, a single nucleotide was replaced in the heterozygous state of C.500 G>A, leading to the replacement of the amino acid p.R167Q. Identification of the VHL gene mutation required genetic counseling of all family members, during which a similar mutation was identified in the younger brother. Surgical treatment is the main method of treating FHL syndrome, but advances in genetic research technologies provide new opportunities for the treatment of tumors associated with this syndrome.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Stavropol State Medical University; Regional endocrinological dispensary.
- Stavropol State Medical University.
- Stavropol Regional Clinical Perinatal Center №1.
Zitieren
APA
Atanesyan, R. A., Klimov, L. Y., Vdovina, T. M., Saneeva, G. A., Andreeva, E. I., & Gasparian, I. K. (2025). A Family case of von Hippel-Lindau syndrome. Problems of Endocrinology. https://doi.org/10.14341/probl13510
Vancouver
Atanesyan RA, Klimov LY, Vdovina TM, Saneeva GA, Andreeva EI, Gasparian IK. A Family case of von Hippel-Lindau syndrome. Problems of Endocrinology. 2025. doi:10.14341/probl13510
BibTeX
@article{Atanesyan2025,
author = {Atanesyan, R A and Klimov, L Y and Vdovina, T M and Saneeva, G A and Andreeva, E I and Gasparian, I K},
title = {A Family case of von Hippel-Lindau syndrome},
journal = {Problems of Endocrinology},
year = {2025},
doi = {10.14341/probl13510}
}
EUVIMED